The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.

Role of selectins in the pathogenesis of multiple myeloma.

Print

Sub-category:
Tumor/Cell Biology

Category:
Tumor Biology

Meeting:
2009 ASCO Annual Meeting

Session Type and Session Title:
General Poster Session, Tumor Biology and Human Genetics

Abstract No:
11103

Citation:
J Clin Oncol 27:15s, 2009 (suppl; abstr 11103)

Author(s):
A. Azab, F. Azab, J. Runnels, A. M. Roccaro, J. L. Magnani, A. Sarkar, K. C. Anderson, C. P. Lin, I. M. Ghobrial; Dana-Farber Cancer Institute, Boston, MA; GlycoMimetics Inc.; Massachusetts General Hospital, Boston, MA

Abstract Disclosures

Faculty and Discussant Disclosures

Annual Meeting Planning Committee Disclosures

2009 Annual Meeting Proceedings Part I Errata

Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.


Abstract:

Background: Multiple myeloma (MM) is characterized by the disseminated involvement of the bone-marrow (BM), and its progression involves a continuous circulation of the MM cells (MMCs) in the peripheral blood and homing back to the BM. Selectins are adhesion molecules involved in the primary interaction of lymphocytes with the endothelial cells (ECs) of blood vessels. In this study we studied the role selectins in the pathogenesis of MM. Methods: We have characterized the expression of E, L and P-selectins and their ligands on MM cell lines, patient sample and plasma cells from normal subjects (NPCs). We have tested the effect of blockade of each of the selectins and selectin-ligands on the interaction of MMCs with ECs. Moreover, we tested the effect of a pan selectin inhibitor on MMCs adhesion to ECs, and trans-well (through filter) and trans-endothelial SDF1-induced migration in vitro, and characterized its effect on cytoskeletal signaling induced by the interaction of MMCs and ECs. Moreover, we have tested the effect of the inhibitor on homing of MMCs to the BM in mice using in vivo flow cytometry to detect the number of circulating cells, and in vivo confocal microscopy to directly visualize the homing. Results: All MM cell lines and patient samples had low expression of all selectins and high expression of L and P, but not E, selectin ligands. While NPCs showed low expression of all selectins and ligands. Blockade of L and P-selectin ligands reduced the interaction of MMCs with ECs in vitro, while blockade of E-selectin ligand or any of selectins did not show any effect. The pan-selectin inhibitor reduced the interaction of MMCs with ECs in vitro, did not alter their SDF1-induced migration through filter, but reduced significantly the migration through ECs. The inhibitor inhibited the activation of FAK and ERK induced by interaction of MMCs and ECs. Moreover, the selectin inhibitor extending the circulation time of MM cells in mice, and reduced the homing of MMCs. Conclusions: We found that L and P selectin ligands are highly expressed in MMCs compared to NPCs, and that those play a major role in homing of MMCs to the BM. Moreover, the pan-selectin inhibitor prevented the homing of MMCs to the BM. This provides a basis for testing the effect of the inhibitor on MM tumor progression and initiation.


  Associated Presentation(s):

    

1. Role of selectins in the pathogenesis of multiple myeloma.

Meeting: 2009 ASCO Annual Meeting
Presenter: Abdel Kareem Azab
Session: Tumor Biology and Human Genetics (General Poster Session)


  Other Abstracts in this Sub-Category:

    

1. Detection of MSC-like cells in soft tissue sarcoma cell lines and primary tumors.

Meeting: 2009 ASCO Annual Meeting   Abstract No: 11000   First Author: S. Wirths
Category: Tumor Biology - Tumor/Cell Biology

    

2. Characterizing the clinical relevance of an embryonic stem cell phenotype in lung adenocarcinoma.

Meeting: 2009 ASCO Annual Meeting   Abstract No: 11001   First Author: M. M. Stevenson
Category: Tumor Biology - Tumor/Cell Biology

    

3. Use of multiplex mutation genotyping to identify novel and protective mutations in breast cancer.

Meeting: 2009 ASCO Annual Meeting   Abstract No: 11004   First Author: K. Kalinsky
Category: Tumor Biology - Tumor/Cell Biology

    

More...


  Abstracts by A. Azab:

    

1. MicroRNAs 15a and 16-1 regulates tumor proliferation in multiple myeloma.

Meeting: 2009 ASCO Annual Meeting   Abstract No: e14640   First Author: A. M. Roccaro
Category: Developmental Therapeutics: Molecular Therapeutics - Epigenetic Strategies

    

2. Role of selectins in the pathogenesis of multiple myeloma.

Meeting: 2009 ASCO Annual Meeting   Abstract No: 11103   First Author: A. Azab
Category: Tumor Biology - Tumor/Cell Biology

    

More...


  Presentations by A. Azab:

    

1. Role of selectins in the pathogenesis of multiple myeloma.

Meeting: 2009 ASCO Annual Meeting
Presenter: Abdel Kareem Azab, PhD
Session: Tumor Biology and Human Genetics (General Poster Session)

    

More...


  Educational Book Manuscripts by A. Azab:

    

No items found.





This online resource is supported by:


 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005-2011 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.
Feedback Form